We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Deep Learning Digital Microscope Scanner Detects Malaria

By LabMedica International staff writers
Posted on 09 Dec 2020
Print article
Image: Microscopic field of view showing the detection of P. falciparum parasites in DAPI-stained thin smears: (1) infected red blood cells (RBCs), (2) normal RBCs, (3) leukocytes and (4) fluorescent debris (Photo courtesy of University of Helsinki).
Image: Microscopic field of view showing the detection of P. falciparum parasites in DAPI-stained thin smears: (1) infected red blood cells (RBCs), (2) normal RBCs, (3) leukocytes and (4) fluorescent debris (Photo courtesy of University of Helsinki).
Malaria remains a major global health problem with a need for improved field-usable diagnostic tests. Light microscopy assessment of blood smears to detect Plasmodium parasites remains the diagnostic gold standard and allows detection and quantification of Plasmodium species while also being more sensitive than rapid diagnostic tests (RDTs).

Various staining methods have been proposed for microscopy identification of malaria parasites in blood smears, with Giemsa staining being the standard method. As visual analysis of blood smears is time-consuming and subjective, fluorescent staining methods have been proposed to facilitate the sample analysis process.

A team of medical scientists from the University of Helsinki (Helsinki, Finland) and their colleagues collected 125 thin blood films from patients with microscopy-confirmed P. falciparum infections in rural Tanzania, prior to and after initiation of artemisinin-based combination therapy. The number of asexual parasites and gametocytes was determined by counting the number of visible parasites per 200 white blood cells (WBCs) using a hand tally counter.

The team developed a portable, low-cost digital microscope scanner, capable of both brightfield and fluorescence imaging. They used the instrument to digitize blood smears, and applied deep learning (DL) algorithms to detect P. falciparum parasites. For the digitization of the samples they used a prototype of a portable, digital microscope scanner, developed and patented by the University of Helsinki for point-of-care (POC) scanning of biological samples. The samples were stained using the 4′,6-diamidino-2-phenylindole (DAPI) fluorogen and digitized using the prototype microscope scanner.

The investigators reported that detection of P. falciparum parasites in the digitized thin blood smears was possible both by visual assessment and by DL-based analysis with a strong correlation in results (r = 0.99). A moderately strong correlation was observed between the DL-based thin smear analysis and the visual thick smear-analysis (r = 0.74). Low levels of parasites were detected by DL-based analysis on day three following treatment initiation, but a small number of fluorescent signals were detected also in microscopy-negative samples.

The authors concluded that quantification of P. falciparum parasites in DAPI-stained thin smears is feasible using DL-supported, point-of-care digital microscopy, with a high correlation to visual assessment of samples. Fluorescent signals from artifacts in samples with low infection levels represented the main challenge for the digital analysis, thus highlighting the importance of minimizing sample contaminations. The proposed method could support malaria diagnostics and monitoring of treatment response through automated quantification of parasitaemia and is likely to be applicable also for diagnostics of other Plasmodium species and other infectious diseases. The study was published on November 17, 2020 in the journal PLOS ONE.

Related Links:
University of Helsinki

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.